LXEO Lexeo Therapeutics Inc.
52
$13.77
$0.08
(0.58%)
| Watchers | 52 |
| 52-Wk Low | $9.00 |
| 52-Wk High | $22.33 |
| Market Cap | $366.91M |
| Volume | 78,474.00 |
| 52-Wk High | $22.33 |
| 52-Wk Low | $9.00 |
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity FinancingGlobe Newswire • 2 months ago
Lexeo extends runway into 2027 with private placement co-led by Braidwell LP and Adage Capital Partners LP with participation from new and existing investors including RA Capital Management, Surveyor...
Share to Feed
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Lexeo announces $95.0M equity financing, which in addition to 2023 year-end cash and cash equivalents of $121.5M, extends runway to fund operations into 2027 Reports frataxin protein expression data...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Lexeo extends runway into 2027 with private placement co-led by Braidwell LP and Adage Capital Partners LP, with participation from new and existing investors including RA Capital Management...
Lexeo Therapeutics GAAP EPS of -$0.86 misses by $0.15...
Lexeo Therapeutics, Inc. (NASDAQ:LXEO Get Free Report) has been assigned an average recommendation of Buy from the six analysts that are presently covering the company...
Lexeo Therapeutics, Inc. (LXEO) has released an update to notify the public and investors about a regulation fd disclosure. Lexeo Therapeutics, Inc...
NEW YORK, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined...